uniQure N.V. Contracts & Agreements

79 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Termination Agreement, dated July 22, 2024, by and between uniQure biopharma B.V. and Pierre Caloz
Termination Agreements
uniQure N.V.
2024
Assignment and Assumption of Lease, dated July 22, 2024, by and between uniQure, Inc. and Genezen MA, Inc
Lease Agreements
uniQure N.V.
2024
Asset Purchase Agreement, by and among uniQure Inc., uniQure biopharma B.V., Genezen Holdings Inc. and Genezen MA, Inc., dated as of June 29, 2024
Purchase Agreements
uniQure N.V.
2024
Consent and Amendment No. 2 to Loan and Security Agreement, dated June 28, 2024, by and among uniQure biopharma, B.V., uniQure, Inc., uniQure IP B.V., the Company and Hercules...
Loan Agreements
uniQure N.V.
2024
Landlord Consent to Assignment and Assumption of Lease and Third Amendment to Lease, dated June 28, 2024, by and among Hartwell Innovation Campus, LLC, uniQure, Inc. and Genezen...
Lease Agreements
uniQure N.V.
2024
Amended and Restated 2014 Share Incentive Plan of uniQure N.V. (conformed to include the Second Amendment to the Amended and Restated 2014 Share Incentive Plan attached as...
Bonus & Incentive Agreements
uniQure N.V.
2024
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
uniQure N.V.
2024
Employment Agreement dated July 30, 2021 between Corlieve Therapeutics AG and Richard Porter
Employment Agreements
uniQure N.V.
2024
First Amended Employment Agreement dated April 1, 2022 between Corlieve Therapeutics AG and Richard Porter
Employment Agreements
uniQure N.V.
2024
Letter Agreement dated October 5, 2023, by and between Richard Porter and Corlieve Therapeutics AG
uniQure N.V.
2024
Employment Agreement dated June 13, 2023 between uniQure, Inc. and Jeannette Potts
Employment Agreements
uniQure N.V.
2024
Amended and Restated 2014 Share Incentive Plan of uniQure N.V. (conformed to include the First Amendment to the Amended and Restated 2014 Share Incentive Plan attached as Appendix...
Bonus & Incentive Agreements
uniQure N.V.
2023
Termination and Consulting Agreement, effective October 4, 2023, by and between uniQure, Inc. and Ricardo Dolmetsch, Ph.D
Consulting Agreements
uniQure N.V.
2023
Amendment No. 1 to Third Amended and Restated Loan and Security Agreement, dated as of May 12, 2023, by and among uniQure biopharma, B.V., uniQure, Inc., uniQure IP B.V., uniQure...
Loan Agreements
uniQure N.V.
2023
Royalty Purchase Agreement, dated May 12, 2023, by and between uniQure biopharma B.V. and HemB SPV, L.P
Purchase Agreements
uniQure N.V.
2023
Consulting Agreement, effective March 31, 2023, by and between uniQure, Inc., and Alex Kuta
Consulting Agreements
uniQure N.V.
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
uniQure N.V.
2023
Lease Agreement relating to 91 Hartwell Avenue, Lexington, Massachusetts, dated as of February 1, 2022, by and between uniQure Inc. and NRL 91 Hartwell LLC
Lease Agreements
uniQure N.V.
2022
Lease Agreement relating to 20 Maguire Road, Lexington, Massachusetts, dated as of December 22, 2021, by and between uniQure Inc. and G&I IX/GP4 20 Maguire LLC
Lease Agreements
uniQure N.V.
Biotechnology
MA
2022
Third Amended and Restated Loan and Security Agreement as of December 15, 2021, by and among uniQure biopharma B.V., uniQure Inc., uniQure IP B.V., the Company and Hercules...
Loan Agreements
uniQure N.V.
Biotechnology
2022
Form of Performance Stock Unit Award, effective December 8, 2021 under the 2014 Share Incentive Plan
Bonus & Incentive Agreements
uniQure N.V.
2022
Form of Restricted Stock Unit Award, effective December 8, 2021, under the 2014 Share Incentive Plan
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2022
Form of Share Option Agreement, effective December 8, 2021, under the 2014 Share Incentive Plan
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
uniQure N.V.
2022
Consent and Amendment No. 3 to Second Amended and Restated Loan and Security Agreement, dated July 30, 2021, by and among the Registrant, Hercules Capital Inc., and the other...
Loan Agreements
uniQure N.V.
2021
t Equity Side Letter, effective May 17, 2021, by and between uniQure N.V. and Pierre Caloz
uniQure N.V.
2021
tAmended and Restated Employment Agreement, effective June 15, 2021, by and between uniQure biopharma B.V. and Christian Klemt
Employment Agreements
uniQure N.V.
2021
t Employment Agreement, effective May 17, 2021, by and between uniQure biopharma B.V. and Pierre Caloz
Employment Agreements
uniQure N.V.
Biotechnology
2021
t2014 Share Incentive Plan, Amended and Restated, effective as of June 16, 2021
Bonus & Incentive Agreements
uniQure N.V.
2021
Sale and Purchase Agreement, executed June 21, 2021, by and between uniQure N.V. and Corlieve Therapeutics SAS
Purchase Agreements
uniQure N.V.
2021
Cooperation Agreement, dated as of April 16, 2021, by and among uniQure N.V., ForUniqure B.V., Forbion 1 Management B.V., Forbion International Management B.V., and Forbion...
Management Agreements
uniQure N.V.
2021
Sales Agreement dated March 1, 2021 by and between uniQure N.V. and SVB Leerink LLC
Sales Agreements
uniQure N.V.
Biotechnology
NY
2021
Amendment No. 2 to Second Amended and Restated Loan and Security Agreement as of January 29, 2021 by and among uniQure Biopharma B.V., uniQure, Inc., uniQure IP B.V., the Company...
Loan Agreements
uniQure N.V.
Biotechnology
2021
Amendment to Collaboration and License Agreement by and between uniQure Biopharma B.V. and Bristol-Myers Squibb Company dated December 1, 2020
Collaboration Agreements
uniQure N.V.
2021
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
uniQure N.V.
2021
103* Employment agreement, executed September 14, 2020, by and between uniQure Inc. and Ricardo Dolmetsch
Employment Agreements
uniQure N.V.
Biotechnology
MA
2020
Separation agreement, executed August 25, 2020, by and between uniQure biopharma B.V. and Sander van Deventer
Separation Agreements
uniQure N.V.
2020
Separation agreement, executed August 25, 2020, by and between uniQure Inc. and Robert Gut
Separation Agreements
uniQure N.V.
2020
Sales Agreement dated March 2, 2020 by and between uniQure N.V. and SVB Leerink LLC
Sales Agreements
uniQure N.V.
2020
Amended and Restated Employment Agreement, executed March 1, 2020 by and between uniQure Inc. and Jonathan Garen
Employment Agreements
uniQure N.V.
2020
Amended and Restated Employment Agreement, executed March 1, 2020 by and between uniQure Inc. and Maria Cantor
Employment Agreements
uniQure N.V.
2020
Amended and Restated Employment Agreement, executed March 1, 2020 by and between uniQure Inc. and Dr. Robert Gut
Employment Agreements
uniQure N.V.
Biotechnology
MA
2020
Amended and Restated Employment Agreement, executed March 1, 2020 by and between uniQure biopharma B.V. and Christian Klemt
Employment Agreements
uniQure N.V.
Biotechnology
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
uniQure N.V.
Biotechnology
2020
Collaboration and License Agreement by and between 4D Molecular Therapeutics, Inc and uniQure biopharma B.V., dated August 6, 2019
Collaboration Agreements
uniQure N.V.
Biotechnology
NY
2019
Amended and Restated Collaboration Agreement by and between 4D Molecular Therapeutics, Inc and uniQure biopharma B.V., dated August 6, 2019
Collaboration Agreements
uniQure N.V.
2019
Separation Agreement, executed September 16, 2019, by and between the Company and Dr. Scott McMillan
Separation Agreements
uniQure N.V.
2019
Employment Agreement, executed September 17, 2019, by and between the Company and Dr. Sander van Deventer
Employment Agreements
uniQure N.V.
Biotechnology
2019
Amended and Restated Employment Agreement, executed September 17, 2019, by and between the Company and Dr. Kuta
Employment Agreements
uniQure N.V.
2019
Underwriting Agreement between the Company, Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives for the underwriters named therein, dated as of September 5, 2019
Underwriting Agreements
uniQure N.V.
2019
Second Amendment Lease relating to 113 Hartwell Avenue, Lexington Massachusetts, dated as of June 17, 2019, by and between the Company and King 113 Hartwell LLC
Lease Agreements
uniQure N.V.
2019
Form of Share Option Agreement, effective June 18, 2019, under the 2014 Share Incentive Plan
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2019
Employment Agreement dated August 20, 2018 by and between uniQure, Inc. and Dr. Robert Gut
Employment Agreements
uniQure N.V.
2019
Amendment No. 1 to Second Amended and Restated Loan and Security Agreement dated December 6, 2018
Loan Agreements
uniQure N.V.
Biotechnology
2018
113 Hartwell Avenue Lexington, Massachusetts (the Building) FIRST AMENDMENT As of November 9, 2018 (Execution Date)
uniQure N.V.
Biotechnology
2018
Underwriting Agreement between the Company and Leerink Partners LLC, as representative for the underwriters named therein, dated as of May 2, 2018
Underwriting Agreements
uniQure N.V.
2018
Form of Restricted Stock Unit Award under the 2014 Share Incentive
Bonus & Incentive Agreements
uniQure N.V.
2018
Form of Performance Stock Unit Award under the 2014 Share Incentive Plan
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2018
Letter agreement dated October 26, 2017 between uniQure N.V. and Matthew Kapusta, amending Mr. Kapustas employment agreement dated December 9, 2014, as amended
Employment Agreements
uniQure N.V.
Biotechnology
2017
Underwriting Agreement between the Company and Leerink Partners LLC, as representative for the underwriters named therein, dated as of October 24, 2017
Underwriting Agreements
uniQure N.V.
Biotechnology
NY
2017
Assignment and License Agreement dated April 17, 2017 between Professor Paolo Simioni and uniQure biopharma B.V
License Agreements
uniQure N.V.
2017
Sales Agreement dated September 15, 2017 by and between uniQure N.V. and Leerink Partners LLC
Sales Agreements
uniQure N.V.
2017
uniQure biopharma B.V. Paasheuvelweg 25a 1105BP Amsterdam The Netherlands
uniQure N.V.
2017
employment AGREEMENT PURSUANT TO SECTION 7:610 (et seq.) of the Dutch Civil Code (DCC)
Employment Agreements
uniQure N.V.
Biotechnology
2017
EMPLOYMENT AGREEMENT
Employment Agreements
uniQure N.V.
2017
employment AGREEMENT PURSUANT TO SECTION 7:610 (et seq.) of the Dutch Civil Code (DCC)
Employment Agreements
uniQure N.V.
2017
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT - EXCLUSIVE and NON-EXCLUSIVE COVER PAGE
License Agreements
uniQure N.V.
2017
CO-DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
uniQure N.V.
Biotechnology
2017
EXCLUSIVE LICENSE AGREEMENT
License Agreements
uniQure N.V.
2017
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT - NONEXCLUSIVE COVER PAGE
License Agreements
uniQure N.V.
Biotechnology
2017
uniQure N.V. Performance Share Unit Agreement Granted Under 2014 Share Incentive Plan, Amended and Restated effective as of June 15, 2016 NOTICE OF GRANT
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2017
uniQure N.V. Restricted Share Unit Agreement Granted Under 2014 Share Incentive Plan, As Amended and Restated NOTICE OF GRANT
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2017
uniQure N.V. Share Option Agreement Granted Under 2014 Share Incentive Plan, Amended and Restated effective as of June 15, 2016
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2017
uniQure N.V. Share Option Agreement
Share Agreements
uniQure N.V.
2017
uniQure N.V. 2014 Share Incentive Plan (Amended and Restated effective as of June 15, 2016)
Bonus & Incentive Agreements
uniQure N.V.
Biotechnology
2017
EMPLOYMENT AGREEMENT
Employment Agreements
uniQure N.V.
Biotechnology
MA
2017
CONSULTANCY SERVICES AGREEMENT
Services Agreements
uniQure N.V.
Biotechnology
2017
UNIQURE SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT
Loan Agreements
uniQure N.V.
2017
(signature Lessee)
uniQure N.V.
2017